Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Renee Margossian

Showing results (51-60 of 59) with videos related to

Pageof 6
Sort By:
You have reached the last page of results.This site can display upto 59 results.
Circulation|July 31, 2012
Outcomes of restrictive cardiomyopathy in childhood and the influence of phenotype: a report from the Pediatric Cardiomyopathy RegistrySteven A Webber, Steven E Lipshultz, Lynn A Sleeper, et al.
The American Journal of Cardiology|July 21, 2009
Comparison of echocardiographic and cardiac magnetic resonance imaging measurements of functional single ventricular volumes, mass, and ejection fraction (from the Pediatric Heart Network Fontan Cross-Sectional Study)Renee Margossian, Marcy L Schwartz, Ashwin Prakash, et al.
Journal of the American College of Cardiology|February 25, 2014
Recovery of echocardiographic function in children with idiopathic dilated cardiomyopathy: results from the pediatric cardiomyopathy registryMelanie D Everitt, Lynn A Sleeper, Minmin Lu, et al.
Circulation|July 14, 2010
Enalapril in infants with single ventricle: results of a multicenter randomized trialDaphne T Hsu, Victor Zak, Lynn Mahony, et al.
Congenital Heart Disease|June 18, 2014
Survival data and predictors of functional outcome an average of 15 years after the Fontan procedure: the pediatric heart network Fontan cohortAndrew M Atz, Victor Zak, Lynn Mahony, et al.
Circulation. Heart Failure|September 14, 2010
Ventricular remodeling and survival are more favorable for myocarditis than for idiopathic dilated cardiomyopathy in childhood: an outcomes study from the Pediatric Cardiomyopathy RegistrySusan R Foerster, Charles E Canter, Amy Cinar, et al.
JAMA Cardiology|September 6, 2023
Cardiac Remodeling in Subclinical Hypertrophic Cardiomyopathy: The VANISH Randomized Clinical TrialChristoffer Rasmus Vissing, Anna Axelsson Raja, Sharlene M Day, et al.
Circulation. Heart Failure|December 10, 2019
Baseline Characteristics of the VANISH CohortAnna Axelsson Raja, Ling Shi, Sharlene M Day, et al.
Nature Medicine|September 24, 2021
Valsartan in early-stage hypertrophic cardiomyopathy: a randomized phase 2 trialCarolyn Y Ho, Sharlene M Day, Anna Axelsson, et al.
Pageof 6

Showing results (51-60 of 59) with videos related to

Sort By:
Pageof 6
You have reached the last page of results.This site can display upto 59 results.
Circulation|July 31, 2012
Outcomes of restrictive cardiomyopathy in childhood and the influence of phenotype: a report from the Pediatric Cardiomyopathy RegistrySteven A Webber, Steven E Lipshultz, Lynn A Sleeper, et al.
The American Journal of Cardiology|July 21, 2009
Comparison of echocardiographic and cardiac magnetic resonance imaging measurements of functional single ventricular volumes, mass, and ejection fraction (from the Pediatric Heart Network Fontan Cross-Sectional Study)Renee Margossian, Marcy L Schwartz, Ashwin Prakash, et al.
Journal of the American College of Cardiology|February 25, 2014
Recovery of echocardiographic function in children with idiopathic dilated cardiomyopathy: results from the pediatric cardiomyopathy registryMelanie D Everitt, Lynn A Sleeper, Minmin Lu, et al.
Circulation|July 14, 2010
Enalapril in infants with single ventricle: results of a multicenter randomized trialDaphne T Hsu, Victor Zak, Lynn Mahony, et al.
Congenital Heart Disease|June 18, 2014
Survival data and predictors of functional outcome an average of 15 years after the Fontan procedure: the pediatric heart network Fontan cohortAndrew M Atz, Victor Zak, Lynn Mahony, et al.
Circulation. Heart Failure|September 14, 2010
Ventricular remodeling and survival are more favorable for myocarditis than for idiopathic dilated cardiomyopathy in childhood: an outcomes study from the Pediatric Cardiomyopathy RegistrySusan R Foerster, Charles E Canter, Amy Cinar, et al.
JAMA Cardiology|September 6, 2023
Cardiac Remodeling in Subclinical Hypertrophic Cardiomyopathy: The VANISH Randomized Clinical TrialChristoffer Rasmus Vissing, Anna Axelsson Raja, Sharlene M Day, et al.
Circulation. Heart Failure|December 10, 2019
Baseline Characteristics of the VANISH CohortAnna Axelsson Raja, Ling Shi, Sharlene M Day, et al.
Nature Medicine|September 24, 2021
Valsartan in early-stage hypertrophic cardiomyopathy: a randomized phase 2 trialCarolyn Y Ho, Sharlene M Day, Anna Axelsson, et al.
Pageof 6